Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when NUVL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Delisting (new) — Company requested Nasdaq to delist its shares following merger completion.
NASDAQ: NUVL Nuvalent, Inc. 8-K

Nuvalent acquired for $10.6B, delists from Nasdaq, becomes wholly owned subsidiary

Filed July 15, 2026 · Period ending July 15, 2026 · ~1 min read

5 key changes 3 high relevance 1 red flag 6 sections

Key Changes

  • high

    Nuvalent completed its acquisition on July 15, 2026, becoming a wholly owned subsidiary of the parent company in a transaction valued at approximately $10.6 billion. All outstanding shares were converted to cash at the offer price.

    Item 5.01 — Changes in Control of Registrant verify on EDGAR →
  • high

    Trading halted after market close July 14, 2026. Nuvalent requested Nasdaq delisting and will file Form 15 to suspend SEC reporting obligations, ending its status as a public company.

    Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR →
  • high

    All eight directors resigned at the merger closing and were replaced by the acquirer's designees. All incumbent officers ceased their roles and were replaced by the parent company's officers.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    The acquiring parent financed the $10.6 billion transaction entirely through borrowings under its existing credit facilities.

    Item 5.01 — Changes in Control of Registrant verify on EDGAR →
  • medium

    All stock options and restricted stock units were cancelled and converted to cash at the offer price, with options receiving the spread between offer price and exercise price, and RSUs assuming full vesting.

    Item 2.01 — Completion of Acquisition or Disposition of Assets verify on EDGAR →

Summary

Nuvalent completed its acquisition on July 15, 2026, in a transaction that valued the company's equity at approximately $10.6 billion. The merger was executed under Delaware law Section 251(h) following a successful tender offer, requiring no stockholder vote. All outstanding shares were converted to cash at the offer price, and the company became a wholly owned subsidiary of the acquiring parent.

The delisting from Nasdaq took effect immediately, with trading halted after market close on July 14, 2026. Nuvalent will file Form 15 to suspend its SEC reporting obligations, formally ending its existence as a public company. All directors and officers were replaced by the acquirer's designees at the merger closing.

The parent company financed the entire $10.6 billion acquisition through debt, using borrowings under its existing credit facilities. For Nuvalent shareholders, this filing confirms the transaction has closed. Former shareholders no longer hold equity rights in the company; their only remaining right is to receive the merger consideration for each share held. Stock option and RSU holders received cash payments based on the offer price, with options paid the spread over exercise price and RSUs assuming full vesting.

Section-by-Section Diff

Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation

~300 words

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.

2 Added
Added Board resignation and replacement high

Added in current filing · verify on EDGAR →

at the Effective Time, each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company’s board of directors, and any committee thereof.

All eight directors of Nuvalent resigned effective at the merger closing. This is a standard consequence of a change-of-control transaction where the acquiring entity reconstitutes the board. Justin T. Huang and Kevin T. Ryan, the directors of Purchaser, became the new directors of the surviving corporation.

Added Officer replacement high

Added in current filing · verify on EDGAR →

As of the Effective Time, in accordance with the Merger Agreement, each of the incumbent officers of the Company, as of immediately prior to the Effective Time, ceased to be officers of the Company.

All incumbent officers of Nuvalent ceased their roles at the merger closing. The officers of Purchaser became the officers of the surviving corporation: Justin T. Huang as President and Secretary, Kevin T. Ryan as Vice President and Treasurer, and Hatixhe Hoxha as Assistant Secretary. This reflects the acquirer's complete operational control post-merger.

Event · Item 5.01 — Changes in Control of Registrant

~100 words

Item 5.01 — Changes in Control of Registrant filed; see Key Changes for terms.

1 Added
Added Change in control / acquisition high

Added in current filing · verify on EDGAR →

As a result of the consummation of the Offer and the consummation of the Merger, on July 15, 2026, a change in control of the Company occurred, and at the Effective Time, the Company became a wholly owned subsidiary of Parent. The total equity value of the transaction was approximately $10.6 billion.

Nuvalent was acquired and became a wholly owned subsidiary of a parent company through a tender offer and merger that closed on July 15, 2026. The transaction valued Nuvalent's equity at approximately $10.6 billion. This represents a complete change in control of the company.

Event · Item 3.03 — Material Modification to Rights of Security Holders

~95 words

Nuvalent merger completed; shareholders ceased to have rights except to receive the Offer Price for their shares.

1 Added
Added Merger completion and shareholder rights high

Added in current filing · verify on EDGAR →

At the Effective Time, holders of Shares immediately prior to such time ceased to have any rights as stockholders of the Company (other than their right to receive the Offer Price for each Share held, pursuant to the Merger Agreement).

The merger has closed. Former Nuvalent shareholders no longer hold equity rights in the company; their only remaining right is to receive the merger consideration (the Offer Price) for each share they held. This is the standard outcome when a public company is acquired and ceases to exist as an independent entity.

Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule

~200 words

Nuvalent delisted from Nasdaq following merger consummation, with trading halted July 14 and deregistration underway.

2 Added
Added Nasdaq delisting and deregistration high

Added in current filing · verify on EDGAR →

the Company (i) notified The Nasdaq Stock Market LLC (“Nasdaq”) of the consummation of the Merger and (ii) requested that Nasdaq (x) halt trading of the Shares effective as of the evening of July 14, 2026 after market close and suspend trading in the Shares prior to market open on the morning of July 15, 2026, and (y) file with the SEC a Notification of Removal from Listing and/or Registration on Form 25 to effect the delisting of all Shares from Nasdaq and the deregistration of such Shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Following merger completion, Nuvalent requested Nasdaq halt trading after market close on July 14, 2026 and delist the shares. The company also requested deregistration under Section 12(b) of the Exchange Act. This is the standard process when a public company is acquired and ceases to be a standalone public entity.

Added SEC reporting suspension high

Added in current filing · verify on EDGAR →

The Company intends to file with the SEC a Certification and Notice of Termination of Registration on Form 15 under the Exchange Act, requesting that the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act be suspended.

Nuvalent will file Form 15 to suspend its SEC reporting obligations under Sections 13 and 15(d) of the Exchange Act. This terminates the company's ongoing disclosure requirements as a public company, consistent with the merger closing and delisting.

Event · Item 2.01 — Completion of Acquisition or Disposition of Assets

~700 words

Item 2.01 — Completion of Acquisition or Disposition of Assets filed; see Key Changes for terms.

4 Added
Added Merger completion high

Added in current filing · verify on EDGAR → · paraphrased

On July 15, 2026, Purchaser irrevocably accepted for payment all Shares that were validly tendered and not validly withdrawn pursuant to the Offer prior to the Expiration Time. On July 15, 2026, the Merger was completed pursuant to Section 251(h) of the DGCL, with no vote of the Company's stockholders required. Upon the consummation of the Merger, the Company became a direct wholly owned subsidiary of Parent.

Nuvalent completed its acquisition on July 15, 2026, becoming a wholly owned subsidiary of the parent company. The merger was executed under Delaware law Section 251(h), which allowed completion without a stockholder vote after the tender offer succeeded. All validly tendered shares were accepted for payment at the offer price.

Added Share conversion high

Added in current filing · verify on EDGAR →

At the effective time of the Merger (the “Effective Time”), each Share issued and outstanding immediately prior to the Effective Time (other than any Shares (i) held in the treasury of the Company or owned by the Company or the Company’s subsidiary immediately prior to the Effective Time, (ii) owned by Ultimate Parent, Parent, Purchaser or any direct or indirect wholly owned subsidiary of Ultimate Parent, Parent or Purchaser immediately prior to the Effective Time and (iii) held by stockholders who have properly demanded appraisal of such Shares in accordance with the DGCL) was converted into the right to receive an amount in cash equal to the Offer Price, less applicable withholding of taxes.

All outstanding shares (except treasury shares, acquirer-owned shares, and shares subject to appraisal rights) were converted to cash at the offer price. Shareholders received cash consideration less applicable tax withholdings. This represents the final step in the acquisition, with equity holders cashed out.

Added Stock option treatment medium

Added in current filing · verify on EDGAR →

In addition, at the Effective Time, each option to purchase Shares (a “Company Stock Option”) that was outstanding immediately prior to the Effective Time was cancelled and in exchange therefor the holder became entitled to receive an amount in cash, without interest and less applicable tax withholdings, equal to (i) the total number of Shares subject to such Company Stock Option immediately prior to the Effective Time (assuming full vesting of such Company Stock Option), multiplied by (ii) the excess, if any, of the Offer Price over the applicable exercise price per Share under such Company Stock Option.

All outstanding stock options were cancelled at the merger's effective time. Option holders received cash equal to the number of shares underlying their options (assuming full vesting) multiplied by the spread between the offer price and the exercise price. Out-of-the-money options received no payment.

Added Restricted stock unit treatment medium

Added in current filing · verify on EDGAR →

Further, at the Effective Time, each restricted stock unit denominated in Class A Shares that was subject solely to time-based vesting (a “Company RSU”) that was outstanding immediately prior to the Effective Time was cancelled and in exchange therefor the holder became entitled to receive an amount in cash, without interest and less applicable tax withholdings, equal to (i) the total number of Shares subject to (or deliverable under) such Company RSU immediately prior to the Effective Time (assuming full vesting of such Company RSU), multiplied by (ii) the Offer Price.

All time-based restricted stock units were cancelled and converted to cash at the offer price, assuming full vesting. Performance-based RSUs were similarly cancelled and converted to cash assuming performance goals were achieved in full. This accelerated vesting treatment is standard in change-of-control transactions.

Event · Item 5.03 — Amendments to Articles of Incorporation or Bylaws

~100 words

Nuvalent amended and restated its certificate of incorporation and bylaws in connection with a merger agreement.

1 Added
Added Certificate of incorporation and bylaws amendment high

Added in current filing · verify on EDGAR →

Pursuant to the terms of the Merger Agreement, as of the Effective Time, the Company’s third amended and restated certificate of incorporation was amended and restated in its entirety, and the Company’s amended and restated bylaws were amended and restated in their entirety.

Nuvalent amended and restated both its certificate of incorporation and bylaws in their entirety as part of a merger agreement. The filing references a 'Merger Agreement' and 'Effective Time' but provides no details about the merger itself, the counterparty, or the substantive changes to the governing documents.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jul 16, 2026 · How we verify